These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15728290)

  • 1. "Off" gait freezing and temporal discrimination threshold in patients with Parkinson disease.
    Lee MS; Kim HS; Lyoo CH
    Neurology; 2005 Feb; 64(4):670-4. PubMed ID: 15728290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of bilateral differences in the loci of tactile stimulation is impaired in subjects with Parkinson's disease.
    Zia S; Cody FW; O'Boyle DJ
    Clin Anat; 2003 May; 16(3):241-7. PubMed ID: 12673819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective temporal discrimination of passive movements in Parkinson's disease.
    Fiorio M; Stanzani C; Rothwell JC; Bhatia KP; Moretto G; Fiaschi A; Tinazzi M
    Neurosci Lett; 2007 May; 417(3):312-5. PubMed ID: 17367930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Freezing of gait is a symptom of Parkinson disease].
    Mezzarobba S; Bandel D; Capus L; Torre P; Moretti R
    Recenti Prog Med; 2004 Sep; 95(9):418-21. PubMed ID: 15473380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gait analysis in patients with Parkinson's disease off dopaminergic therapy.
    Svehlík M; Zwick EB; Steinwender G; Linhart WE; Schwingenschuh P; Katschnig P; Ott E; Enzinger C
    Arch Phys Med Rehabil; 2009 Nov; 90(11):1880-6. PubMed ID: 19887212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atomoxetine for freezing of gait in Parkinson disease.
    Jankovic J
    J Neurol Sci; 2009 Sep; 284(1-2):177-8. PubMed ID: 19361809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease.
    Perrotta A; Serrao M; Bartolo M; Valletta L; Locuratolo N; Pujia F; Fattapposta F; Bramanti P; Amabile GA; Pierelli F; Parisi L
    Clin Neurophysiol; 2005 Sep; 116(9):2091-8. PubMed ID: 16029959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
    Yamada K; Goto S; Hamasaki T; Kuratsu JI
    Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal temporal discrimination threshold in patients with multiple system atrophy.
    Lyoo CH; Lee SY; Song TJ; Lee MS
    Mov Disord; 2007 Mar; 22(4):556-9. PubMed ID: 17260339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral coordination of walking and freezing of gait in Parkinson's disease.
    Plotnik M; Giladi N; Hausdorff JM
    Eur J Neurosci; 2008 Apr; 27(8):1999-2006. PubMed ID: 18412621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
    Isacson D; Bingefors K; Kristiansen IS; Nyholm D
    Acta Neurol Scand; 2008 Dec; 118(6):379-86. PubMed ID: 18547273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease.
    Ferraye MU; Debû B; Fraix V; Xie-Brustolin J; Chabardès S; Krack P; Benabid AL; Pollak P
    Neurology; 2008 Apr; 70(16 Pt 2):1431-7. PubMed ID: 18413568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study.
    Amboni M; Stocchi F; Abbruzzese G; Morgante L; Onofrj M; Ruggieri S; Tinazzi M; Zappia M; Attar M; Colombo D; Simoni L; Ori A; Barone P; Antonini A;
    Parkinsonism Relat Disord; 2015 Jun; 21(6):644-9. PubMed ID: 25899545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
    Devos D; Bordet R; Defebvre L
    Rev Neurol (Paris); 2010 Feb; 166(2):168-77. PubMed ID: 19811797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term monitoring of gait in Parkinson's disease.
    Moore ST; MacDougall HG; Gracies JM; Cohen HS; Ondo WG
    Gait Posture; 2007 Jul; 26(2):200-7. PubMed ID: 17046261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic influence on disturbed spatial discrimination in Parkinson's disease.
    Shin HW; Kang SY; Sohn YH
    Mov Disord; 2005 Dec; 20(12):1640-3. PubMed ID: 16092109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute vs chronic effects of l-dopa on bladder function in patients with mild Parkinson disease.
    Brusa L; Petta F; Pisani A; Moschella V; Iani C; Stanzione P; Miano R; Finazzi-Agrò E
    Neurology; 2007 May; 68(18):1455-9. PubMed ID: 17470746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sequence effect and gait festination in Parkinson disease: contributors to freezing of gait?
    Iansek R; Huxham F; McGinley J
    Mov Disord; 2006 Sep; 21(9):1419-24. PubMed ID: 16773644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of basal ganglia on upper limb locomotor synergies. Evidence from deep brain stimulation and L-DOPA treatment in Parkinson's disease.
    Crenna P; Carpinella I; Lopiano L; Marzegan A; Rabuffetti M; Rizzone M; Lanotte M; Ferrarin M
    Brain; 2008 Dec; 131(Pt 12):3410-20. PubMed ID: 18952669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proprioceptive deficits in Parkinson's disease patients with freezing of gait.
    Tan T; Almeida QJ; Rahimi F
    Neuroscience; 2011 Sep; 192():746-52. PubMed ID: 21745543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.